The open offer to acquire over 44,560,177 (4.45 crore) equity shares constituting 26% stake of Camlin Fine Sciences augurs well for the company, brokerage firm Axis Securities said, recommending a ‘buy’ on the stock.
The open offer to acquire over 44,560,177 (4.45 crore) equity shares constituting 26% stake of Camlin Fine Sciences augurs well for the company, brokerage firm Axis Securities said, recommending a ‘buy’ on the stock.